Due to the downward trend of COVID-19 cases, the Indonesia government will slowly stop subsidizing the treatment costs of COVID-19 patients. The source of funding for COVID-19 treatment will be shifted from the government to the national health insurance program or the JKN managed by BPJS Kesehatan (Social Security Agency).
For more information, read the full news article originally published in ANTARA.
Have anything to say about Indonesia’s health financing and social health protection? Please leave your comments below.
Picture by Andrii Yalanskyi
